Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2003Pharmacogenetics

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJulia KirchheinerUniversität UlmCKChristian D. KleinHeidelberg UniversityIMIngolf MeinekeUniversity of Göttingen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kirchheiner et al. (2003) studied this question.

synapsesocial.com/papers/6a7e1a4748ce9983f2c7f505https://doi.org/10.1097/00008571-200310000-00005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus Nonsmokers1997 · 138 citations
  2. 2Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation*1996 · 176 citations
  3. 3Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: Role of CYP2B6, 2C19 and the 3A subfamily1996 · 118 citations